AU647444B2 - Oxipurinol salt composition for oral administration for treating hyperurecemia - Google Patents

Oxipurinol salt composition for oral administration for treating hyperurecemia

Info

Publication number: AU647444B2
Authority: AU; Australia
Prior art keywords: hyperurecemia; oxipurinol; treating; oral administration; salt composition
Prior art date: 1989-12-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

AU69687/91A

Other versions

AU6968791A (en

Inventor

Veit Nitsche

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Biokinet Chemisches Laboratorium GmbH

Original Assignee

BIOKINET CHEM LAB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-28

Filing date

1990-12-20

Publication date

1994-03-24

1990-12-20 Application filed by BIOKINET CHEM LAB filed Critical BIOKINET CHEM LAB

1991-07-24 Publication of AU6968791A publication Critical patent/AU6968791A/en

1994-03-24 Application granted granted Critical

1994-03-24 Publication of AU647444B2 publication Critical patent/AU647444B2/en

2010-12-20 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

HXNFUBHNUDHIGC-UHFFFAOYSA-N oxypurinol Chemical class O=C1NC(=O)N=C2NNC=C21 HXNFUBHNUDHIGC-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Physical Education & Sports Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU69687/91A 1989-12-28 1990-12-20 Oxipurinol salt composition for oral administration for treating hyperurecemia Ceased AU647444B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
AT0295889A AT396427B (en)	1989-12-28	1989-12-28	PHARMACEUTICAL USE OF OXIPURINOL SALT
AT2958/89		1989-12-28
PCT/AT1990/000126 WO1991009600A1 (en)	1989-12-28	1990-12-20	Oxipurinol salt composition for oral administration for treating hyperurecemia

Publications (2)

Publication Number	Publication Date
AU6968791A AU6968791A (en)	1991-07-24
AU647444B2 true AU647444B2 (en)	1994-03-24

Family

ID=3543074

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU69687/91A Ceased AU647444B2 (en)	1989-12-28	1990-12-20	Oxipurinol salt composition for oral administration for treating hyperurecemia

Country Status (8)

Country	Link
EP (1)	EP0461218B1 (en)
AT (1)	AT396427B (en)
AU (1)	AU647444B2 (en)
DE (1)	DE59003806D1 (en)
DK (1)	DK0461218T3 (en)
ES (1)	ES2062752T3 (en)
RU (1)	RU2016571C1 (en)
WO (1)	WO1991009600A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006083687A1 (en) *	2005-01-28	2006-08-10	Cardiome Pharma Corp.	Crystal salt of xanthine oxidase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3624205A (en) *	1967-04-25	1971-11-30	Burroughs Wellcome Co	Treatment of hyperuricemia in humans
DE3707999A1 (en) *	1986-03-13	1987-09-17	Wellcome Found	USE OF OXYPURINOL TO REDUCE CELL DAMAGE

1989
- 1989-12-28 AT AT0295889A patent/AT396427B/en not_active IP Right Cessation
1990
- 1990-12-20 DK DK91900357.4T patent/DK0461218T3/en not_active Application Discontinuation
- 1990-12-20 ES ES91900357T patent/ES2062752T3/en not_active Expired - Lifetime
- 1990-12-20 AU AU69687/91A patent/AU647444B2/en not_active Ceased
- 1990-12-20 DE DE91900357T patent/DE59003806D1/en not_active Expired - Fee Related
- 1990-12-20 WO PCT/AT1990/000126 patent/WO1991009600A1/en not_active Ceased
- 1990-12-20 EP EP91900357A patent/EP0461218B1/en not_active Expired - Lifetime
1991
- 1991-08-27 RU SU915001702A patent/RU2016571C1/en active

Also Published As

Publication number	Publication date
ES2062752T3 (en)	1994-12-16
AT396427B (en)	1993-09-27
EP0461218B1 (en)	1993-12-08
AU6968791A (en)	1991-07-24
DE59003806D1 (en)	1994-01-20
WO1991009600A1 (en)	1991-07-11
DK0461218T3 (en)	1994-04-18
ATA295889A (en)	1993-01-15
RU2016571C1 (en)	1994-07-30
EP0461218A1 (en)	1991-12-18

Similar Documents

Publication	Publication Date	Title
AU7061687A (en)	1987-10-01	Pharmaceutical composition for treating periodontal diseases
AU1536188A (en)	1988-10-27	Salt-containing pharmaceutical compositions
AU5157590A (en)	1990-08-24	Pharmaceutical compositions for oral administration
AU634746B2 (en)	1993-03-04	Effervescent composition for oral rehydration
AU5970290A (en)	1991-02-07	Dental composition
IL95158A0 (en)	1991-06-10	Pharmaceutical composition for oral administration containing n-acetyl-cysteine
AU3746489A (en)	1990-01-05	Glycosaminoglycan salts, processes for the preparation thereof and pharmaceutical compositions containing them
GB8825892D0 (en)	1988-12-07	Pharmaceutical composition
AU2345988A (en)	1989-04-20	Pharmaceutical composition for piperidinoalkanol-decongestant combination
AU2346088A (en)	1989-08-10	Pharmaceutical composition for piperidinoalkanol derivatives
AU4452789A (en)	1990-05-24	Antibacterial oral composition
GB2232891B (en)	1993-02-03	Pharmaceutical composition
AU4939690A (en)	1990-08-23	Anesthetic oral compositions
ZA893422B (en)	1991-01-30	Pharmaceutical composition
AU647444B2 (en)	1994-03-24	Oxipurinol salt composition for oral administration for treating hyperurecemia
AU3723589A (en)	1990-01-04	Therapeutic composition
AU3510489A (en)	1989-11-30	Pharmaceutical composition for treating tumor
AU2876889A (en)	1989-08-03	Pharmaceutical composition for 4-aroylimidazol-2-ones
AU4102789A (en)	1990-03-08	Treatment compositions
AU3298589A (en)	1989-10-05	New pharmaceutical composition
AU4093789A (en)	1990-03-08	Transermal therapeutic composition
AU1228988A (en)	1988-08-24	Cephalosporin compounds or their salts, process for their preparation, and pharmaceutical compositions
AU7819887A (en)	1988-03-17	Pharmaceutical composition
GB8809329D0 (en)	1988-05-25	Pharmaceutical compositions & treatment
GB8811716D0 (en)	1988-06-22	Pharmaceutical compositions & treatment